安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Edwards Lifesciences - the leader in heart valves hemodynamic . . .
*Edwards Lifesciences Critical Care is now part of BD (Becton, Dickinson and Company) Patients We are dedicated to providing innovative solutions for people fighting cardiovascular disease
- Irvine - Edwards Lifesciences
Edwards is an Equal Opportunity Affirmative Action employer including protected Veterans and individuals with disabilities Follow Edwards on: United States - English
- Edwards Lifesciences Corp - Overview
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives
- Who We Are - Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to
- Locations - Edwards Lifesciences
Learn about our global locations and explore how our talented teams collaborate to meet our collective purpose of improving patients’ lives For a full list of all Edwards locations, click here
- Contact Us - Edwards Lifesciences
Careers at Edwards Discover an exciting career at a company dedicated to improving patient lives I'm a supplier Reach us here if you are, or would like to be, a supplier Other ways to reach us Patient Support Center Whether you are a patient or caring for one, we are here for you Give us a call or send us an email
- Edwards Lifesciences Reports Fourth Quarter Results
Edwards’ guidance for 2025 adjusted operating margins continues to be 27 to 28% with annual operating profit margin expansion thereafter, as outlined at the company’s investor conference Edwards' adjusted Earnings Per Share was $0 59, led by strong top-line performance
- Edwards Lifesciences Reports First Quarter Results
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Mar 31, 2025
|
|
|